Evidence map›Paper›PMID 16437696›Full record

ArticleWorld journal of gastroenterology2005

Possible involvement of leptin and leptin receptor in developing gastric adenocarcinoma.

Liang Zhao, Zhi-Xiang Shen, He-Sheng Luo, Lei Shen

Open access · bronzeAbstract read
In one paragraph

Article in World journal of gastroenterology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Article
  3. Insulin Resistance and Cancer: In Search for a Causal Link.International journal of molecular sciences · 2021
    Review
  4. Article
  5. Role of Obesity in the Tumorigenesis of Gastric Cancer.International journal of preventive medicine · 2020
    Review
  6. Gastric Leptin and Tumorigenesis: Beyond Obesity.International journal of molecular sciences · 2019
    Review
  7. Leptin signaling and cancer chemoresistance: Perspectives.World journal of clinical oncology · 2017
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Liang ZhaoDepartment of Gastroenterology, Renmin Hospital, Wuhan University, Wuhan 430060, Hubei Province, China. airman-zhao@tom.com
Zhi-Xiang Shen
He-Sheng Luo
Lei Shen
Wuhan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo investigate the expression of leptin and leptin receptor (ob-R) in intestinal-type gastric cancer and precancerous lesions, and to explore the possible mechanism and role of the leptin system in developing intestinal-type gastric adenocarcinoma.

methodsImmunohistochemistry was performed to examine the expression of leptin and leptin receptor in archival samples of gastric adenocarcinoma and preneoplastic lesions, including intestinal metaplasia and mild to severe gastric epithelial dysplasia. Positive staining was identified and percentage of positive staining was graded.

resultsDual expression of leptin and leptin receptor were detected in 80% (16/20) intestinal metaplasia, 86.3% (25/30) mild gastric epithelial dysplasia, 86.7% (26/30) moderate gastric epithelial dysplasia, 93.3% (28/30) severe gastric epithelial dysplasia, 91.3% (55/60) intestinal-type gastric adenocarcinoma and 30.0% (9/30) diffuse-type gastric carcinoma. The percentage of dual expression of leptin and leptin receptor in intestinal-type gastric adenocarcinoma was significantly higher than that in diffuse-type gastric adenocarcinoma (c2 = 37.022, P<0.01).

conclusionOur results indicate the presence of an autocrine loop of leptin system in the development of intestinal-type gastric adenocarcinoma.

Indexed as

AdenocarcinomaHumansImmunohistochemistryLeptinMAP Kinase Signaling SystemPhosphatidylinositol 3-KinasesPrecancerous ConditionsReceptors, Cell SurfaceReceptors, LeptinStomach NeoplasmsLEPR protein, humanLeptinPhosphatidylinositol 3-KinasesReceptors, Cell SurfaceReceptors, Leptin

Identifiers

PMID16437696
PMCPMC4727216
OpenAlexW37040883

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.